Strong Top-Line Growth
Full year 2025 revenue of $259.0M, up 41.8% year-over-year from $183M; Q4 2025 revenue of $85.2M, up 43% year-over-year and meeting the upper end of guidance.
Amazfit Branded Product Momentum
Full-year Amazfit branded product revenue grew 51% year-over-year; Q4 Amazfit branded product sales increased 45.4% year-over-year and 12.4% sequentially, driven by broad-based strength across entry-level and premium segments.
Record Gross Margin Expansion
Q4 record gross margin of ~40.4% (CEO cited 40.3%), up ~3.6 percentage points vs Q4 2024 and +2.2 percentage points vs Q3 2025; full-year gross margin was 38.3%, reflecting premium mix and maintained price integrity during promotions.
Improved Profitability Trends
Q4 adjusted net loss attributable to Zepp Health narrowed to $6.4M from an adjusted net loss of $22.5M in Q4 2024; full-year adjusted net loss improved to $31.5M from $56.7M in 2024, showing material reduction in losses year-over-year.
Product & Premiumization Progress
Launched new products across tiers including Active MAX, Active 3 Premium (~$169), T-Rex Ultra 2 (~$550) and T-Rex 3 Pro; premium Adventure series helped elevate ASP and product mix toward higher-margin SKUs.
Ecosystem and Brand Strengthening
Software & services momentum (Zepp OS features like BioCharge and Zepp Coach AI) and strategic athlete partnerships (e.g., Josh Kerr, Grant Fisher) plus HYROX integration to drive credibility, engagement and organic brand exposure.
Cash Flow and Working Capital Improvements
Cash and cash equivalents of $113M as of Dec 31, 2025 (up from $111M a year earlier); inventory reduced to $72.8M from $87.7M in Q3 2025 (down ~17%); another quarter of positive operating cash flow and cumulative debt retired of $58M since 2023.
Confident Near-Term Outlook
Q1 2026 guidance of $50M-$55M revenue, implying ~30%-43% year-over-year growth; company reiterates path to sustained margin expansion and commitment to share repurchase program.